Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
REVENUES    
Total revenues $ 904,067 $ 1,510,835
EXPENSES    
Cost of product sales 355,427 316,513
Cost of product sales-related party 452,495 661,267
General and administrative 1,979,614 269,017
Research and development 597,345 147,641
Research and development-related party 539,425
Sales and marketing 88,844 102,394
Total expenses 3,473,725 2,036,257
LOSS FROM OPERATIONS (2,569,658) (525,422)
OTHER EXPENSE (INCOME), NET    
Change in fair value of warrant liabilities 16,201,400
Interest expense, net 57,364 69,985
Other income, net (250,114) (992)
Total other expense (income), net 16,008,650 68,993
LOSS BEFORE PROVISION FOR INCOME TAXES (18,578,308) (594,415)
PROVISION FOR INCOME TAXES 597 150
NET LOSS $ (18,578,905) $ (594,565)
Net loss per common share, basic and diluted $ (2.12) $ (0.11)
Weighted-average number of shares outstanding, basic and diluted 8,746,250 5,602,214
Net Product Sales [Member]    
REVENUES    
Total revenues $ 484,423 $ 560,651
Net Product Sales-Related Party [Member]    
REVENUES    
Total revenues $ 419,644 $ 950,184